Delivery Order SPE2DR25D9331-SPE2DR26FQQD7
- Not listed
- The Defense Logistics Agency awarded a $16,900.92 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Photrexa Cross-Linking Kit 6ml. The delivery order, which carries an ultimate completion date of January 7, 2026, was issued without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical...
- The Defense Logistics Agency awarded a $12,269.80 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Photrexa Cross-Linking Kit 6ML. The delivery order, issued on January 20, 2026, with an ultimate completion date of February 10, 2026, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This award is issued...
- The Defense Logistics Agency awarded a delivery order valued at $22,534.56 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Photrexa Cross-Linking Kit (6ml). The award, issued on October 31, 2025, with an ultimate completion date of November 24, 2025, represents a firm fixed-price delivery order with no set-aside designation, indicating the contractor competed in the open market. This delivery order is...
- The Defense Logistics Agency awarded a $30,674.50 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Photrexa Cross-Linking Kit 6ml. The delivery order, issued January 12, 2026, with an ultimate completion date of February 3, 2026, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This award is...
- The Defense Logistics Agency issued a $15,337.25 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Photrexa Cross-Linking Kit 6ML. The delivery order, awarded on January 23, 2026, with an ultimate completion date of February 13, 2026, carries no set-aside designation, indicating the vendor competed in an unrestricted procurement process. This award is issued under DMS...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $3,067.45 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Photrexa Cross-Linking Kit 6ml. The delivery order, issued on January 13, 2026, with an ultimate completion date of February 4, 2026, carries no set-aside designation, indicating the award was made through unrestricted federal procurement. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $16,900.92 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of a Photrexa Cross-Linking Kit (6ml). This firm fixed-price delivery order was awarded on November 14, 2025, with an ultimate completion date of December 8, 2025, and will be performed at the vendor's Park Ridge location. The award was issued without a set-aside designation,...
- The Defense Logistics Agency awarded a $5,633.64 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for the supply of Photrexa Cross-Linking Kit (6ml). DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected without a set-aside designation, demonstrating the company's competitive capability in unrestricted federal procurement. The delivery order is scheduled for completion by November 18, 2025, with...
- The Defense Logistics Agency awarded a $8,280.15 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Photrexa Cross-Linking Kit 6ml. The delivery order, issued on October 21, 2025, with an ultimate completion date of November 12, 2025, was executed without a set-aside designation, demonstrating the vendor's competitive capability in unrestricted federal procurement....
- The Defense Logistics Agency awarded a delivery order valued at $7,455.02 to DMS Pharmaceutical Group Inc. for the supply of Photrexa Cross-Linking Kit (6ml). DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected to provide this pharmaceutical product with a firm fixed-price contract type. The delivery order carries an ultimate completion date of July 10, 2025, and was awarded on June 17, 2025, with no set-aside...
- SPE2DR25D9331Indefinite Delivery Contract
- SPE2DR25D9331-SPE2DR26FQQD7Delivery Order
The Defense Logistics Agency awarded a $18,404.70 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Photrexa Cross-Linking Kit (6ML). The contract, issued on February 2, 2026, with an ultimate completion date of February 24, 2026, carries no set-aside designation, indicating the award was made through competitive procurement. Performance will occur at the awardee's location in Park Ridge, Illinois. This delivery order falls under DMS Pharmaceutical Group's broader Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to support recurring pharmaceutical and medical supply needs across Department of Defense healthcare facilities worldwide. The parent IDC, valued at $499,999,999 with a completion date of December 31, 2036, positions DMS Pharmaceutical Group as a critical regional pharmaceutical supplier for military medical operations. The company's established performance across numerous delivery orders and its comprehensive product portfolio spanning branded and generic pharmaceuticals, biologics, vaccines, and specialty medical consumables demonstrate its capability to fulfill the diverse requirements of the federal military medical system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.4k | 2/1/26 |